Rep. Sires introduces legislation supporting global health R&D
April 15, 2013 -- Rep. Albio Sires (D-NJ) has introduced the 21st Century Global Health Technology Act, legislation that aims to encourage US investments in research and development (R&D) for global health products that are affordable, culturally appropriate, and easy to us in low-resourced settings worldwide.
“Each year, millions of people in the developing world die of infectious diseases, malnutrition, and complications of pregnancy and childbirth. The 21st Century Global Health Technology Act supports a long-term program to develop much needed health technologies such as safe injection devices, rapid diagnostics for diseases, technologies for safe delivery, and other innovative health solutions,” said Rep. Sires in a press release.
The bill would also—for the first time—acknowledge the US Agency for International Development’s (USAID) role in the development and scale-up of health technologies for low- and middle-income countries. It would also point out gaps in USAID’s current health research programs, as well as call for more coordination between USAID and other US agencies on global health R&D.
To date, the current Health Tech program at USAID has fostered the development of more than 80 global health products, most of which were in partnership with nonprofit organizations and private industry. The program also helps bolster the US economy and spur job growth nationwide.